Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancerHof, J., Joosten, H. J., Havenga, K. & de Jong, K. P., 15-Mar-2018, In : PLoS ONE. 13, 3, 14 p., e0193385.
Research output: Contribution to journal › Article › Academic › peer-review
BACKGROUND: In patients with resectable synchronous colorectal liver metastases (CRLM), either two-staged or simultaneous resections of the primary tumor and liver metastases are performed. Data on radiofrequency ablation (RFA) for the treatment of CRLM during a simultaneous procedure is lacking. The primary aim was to analyze short-term and long-term outcome of RFA in simultaneous treatment. A secondary aim was to compare simultaneous resection with the colorectal-first approach.
METHODS: Retrospective analysis of 241 patients with colorectal cancer and synchronous CRLM between 2000-2016. Median follow-up was 36.1 months (IQR 18.2-58.8 months). A multivariable analysis was performed to analyze the postoperative morbidity, using the comprehensive complication index. A propensity matched analysis was performed to compare survival rates.
RESULTS: In multivariable analysis, the best predictor of lower complication severity was treatment with RFA (p = 0.040). Higher complication rates were encountered in patients who underwent an abdominoperineal resection (p = 0.027) or age > 60 years (p = 0.022). The matched analysis showed comparable overall survival in RFA treated patients versus patients undergoing a liver resection with a five year overall survival of 39.4% and 37.5%, respectively (p = 0.782). In a second matched analysis, 5-year overall survival rates in simultaneously treated patients (43.8%) was comparable to patients undergoing the colorectal first approach (43.0%, p = 0.223).
CONCLUSIONS: RFA treatment of CRLM in simultaneous procedures is associated with a lower complication severity and non-inferior oncological outcome as compared to partial liver resection. RFA should be considered a useful alternative to liver resection.
|Number of pages||14|
|Publication status||Published - 15-Mar-2018|
- Journal Article, MORBIDITY, MORTALITY, SIMULTANEOUS RESECTION, 2-STAGE HEPATECTOMY, RECTAL-CANCER, HEPATIC RESECTION, OUTCOMES, TUMOR, RECURRENCE, MANAGEMENT